Before we begin, please review the disclaimer on Slide 3. During this call, management may make forward-looking statements ...
Thank you, Larry, and good morning, everyone. As I close out my first full year as CEO, I'm encouraged by our ongoing work to ...
BACKGROUND: BCR-ABL tyrosine kinase inhibitors (TKIs) have been increasingly linked to pulmonary arterial hypertension (PAH) since 2009, although supporting evidence is limited. Our objective was to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results